Modern strategy of diagnosis and treatment of children with heterozygous familial hypercholesterolemia
Familial heterozygous hypercholesterolemia Is an autosomal dominant disease characterized by high levels of low-density lipoprotein cholesterol, leading to an atherosclerotic vascular damage in children and myocardial infarction in 20 -30 years-old individuals. Familial hypercholesterolemia remains...
Main Author: | I. V. Leontyeva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ltd. “The National Academy of Pediatric Science and Innovation”
2020-09-01
|
Series: | Rossijskij Vestnik Perinatologii i Pediatrii |
Subjects: | |
Online Access: | https://www.ped-perinatology.ru/jour/article/view/1198 |
Similar Items
-
Familial hypercholesterolemia: current status of the problem, treatment, and prevention
by: S. A. Bliznyuk, et al.
Published: (2020-11-01) -
Bempedoic Acid for Heterozygous Familial Hypercholesterolemia: From Bench to Bedside
by: Agarwala A, et al.
Published: (2021-05-01) -
Homozygous familial hypercholesterolemia
by: Ravi Kumar Parihar, et al.
Published: (2012-01-01) -
Cataract Surgery in Elderly Subjects with Heterozygous Familial Hypercholesterolemia in Prolonged Treatment with Statins
by: Victoria Marco-Benedí, et al.
Published: (2021-08-01) -
Suboptimal control of lipid levels: results from the non-interventional Centralized Pan-Russian Survey of the Undertreatment of Hypercholesterolemia II (CEPHEUS II)
by: Sergey Boytsov, et al.
Published: (2017-12-01)